TED Ted Baker Plc

RNS Number:8974S
Tepnel Life Sciences PLC
14 March 2007



             Tepnel Life Sciences plc ('Tepnel' or 'the Company')

                       Notice of 2006 Preliminary Results



Manchester, UK, 14th March 2007 Tepnel Life Sciences PLC (AIM: TED), the
international Molecular Diagnostics and Research Products & Services group, will
announce its preliminary results for the year ended 31st December 2006 on
Thursday 15th March 2007.

The results announcement will be released at 7.00am GMT.



                                    - Ends-





For Further Information:

Tepnel Life Sciences plc
Ben Matzilevich, CEO
Carol Smith
Tel: 0161 946 2200

Capital MS&L
Mary Clark or Halina Kukula
Tel: +44 20 7307 5330
Email: mary.clark@capitalmsl.com



Notes to Editors

About Tepnel Life Sciences plc

Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences
products and services group with two divisions, Molecular Diagnostics and
Research Products & Services. The Company has laboratories, manufacturing and
operations in the USA, UK and France with 195 employees.  TLS provides test
kits, reagents and services to two highly synergistic markets, these being
Molecular Diagnostics and Biomedical Research.  The company's strategy has been
to identify high growth niche opportunities within these multi-billion pound
markets.  TLS focuses on these niche opportunities with internally developed
products, patents, expertise and know-how as well as strategic acquisitions, to
develop a leadership position within these defined market segments.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NORZGGMFNFRGNZM

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024